<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00153855</url>
  </required_header>
  <id_info>
    <org_study_id>2004-6-3818</org_study_id>
    <nct_id>NCT00153855</nct_id>
  </id_info>
  <brief_title>Structural Brain Abnormalities in Children Born Prematurely: New Detection Methods and Clinical-Pathological Correlates</brief_title>
  <official_title>Structural Brain Abnormalities in Children Born Prematurely: New Detection Methods and Clinical-Pathological Correlates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Mercy Hospital Kansas City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Philadelphia</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to detect structural brain changes using MRI and to correlate
      these findings with neurodevelopmental assessments in two-year old children previously
      enrolled in the NIH sponsored trial of inhaled Nitric Oxide (iNO) for the prevention of
      Chronic Lung Disease in preterm ventilated infants. It is hypothesized that this imaging will
      identify children with previously undiagnosed brain abnormalities and that the presence of
      structural abnormalities will be associated with deficits in motor, cognitive, and
      neurosensory development.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infants born prematurely are at significant risk for hemorrhagic and ischemic brain injury.
      Despite improved survival rates among this population in recent years, these forms of brain
      injury remain frequent and have considerable consequences. Periventricular leukomalacia
      (PVL), a disease characterized by necrosis of the cerebral white matter in a characteristic
      distribution, is one of the most common types of brain injury seen in premature infants. MRI
      technology now allows for better anatomical resolution resulting in improvements in
      diagnostic accuracy. The current standard practice is not to perform routine MRI examinations
      on premature infants, nor is it routine to perform surveillance brain imaging in children
      after leaving the NICU. In their 2002 Practice Parameter for neuroimaging in the neonate, the
      American Academy of Neurology and the Practice Committee of the Child Neurology Society
      acknowledge the superiority of MRI in detection of brain lesions in premature infants, but
      fall short of recommending routine MRI scanning on the basis of a lack of information
      correlating MRI findings to neurodevelopmental outcomes. We now have a unique opportunity to
      help provide such information.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>January 2005</start_date>
  <completion_date>March 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>50</enrollment>
  <condition>Infant, Premature</condition>
  <condition>Brain Injuries</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  must be participants in trial (NHLBI-UO1-HL62514-05A1 and FDA IND # 58,146 - Roberta A
             Ballard PI) of inhaled Nitric Oxide (iNO) for the prevention of Chronic Lung Disease
             in preterm ventilated infants

          -  gestational age between 24 months and 27 months

        Exclusion Criteria:

          -  history of allergy to sedation agents

          -  medical conditions which may pose a threat to airway integrity (i.e., Pierre-Robin
             sequence, intercurrent respiratory illness)

          -  other conditions which may otherwise place subjects at increased risk for
             complications from sedation and MRI examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Months</minimum_age>
    <maximum_age>27 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberta A Ballard, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Philadelphia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Stevenson DK, Wright LL, Lemons JA, Oh W, Korones SB, Papile LA, Bauer CR, Stoll BJ, Tyson JE, Shankaran S, Fanaroff AA, Donovan EF, Ehrenkranz RA, Verter J. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol. 1998 Dec;179(6 Pt 1):1632-9.</citation>
    <PMID>9855609</PMID>
  </reference>
  <reference>
    <citation>Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol. 1998 Sep;5(3):135-51. Review.</citation>
    <PMID>9777673</PMID>
  </reference>
  <reference>
    <citation>Hack M, Fanaroff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990s. Semin Neonatol. 2000 May;5(2):89-106. Review.</citation>
    <PMID>10859704</PMID>
  </reference>
  <reference>
    <citation>Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA. 2002 Aug 14;288(6):728-37.</citation>
    <PMID>12169077</PMID>
  </reference>
  <reference>
    <citation>Sie LT, van der Knaap MS, van Wezel-Meijler G, Taets van Amerongen AH, Lafeber HN, Valk J. Early MR features of hypoxic-ischemic brain injury in neonates with periventricular densities on sonograms. AJNR Am J Neuroradiol. 2000 May;21(5):852-61.</citation>
    <PMID>10815660</PMID>
  </reference>
  <reference>
    <citation>Inder TE, Huppi PS, Warfield S, Kikinis R, Zientara GP, Barnes PD, Jolesz F, Volpe JJ. Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol. 1999 Nov;46(5):755-60.</citation>
    <PMID>10553993</PMID>
  </reference>
  <reference>
    <citation>Olsén P, Pääkkö E, Vainionpää L, Pyhtinen J, Järvelin MR. Magnetic resonance imaging of periventricular leukomalacia and its clinical correlation in children. Ann Neurol. 1997 Jun;41(6):754-61.</citation>
    <PMID>9189036</PMID>
  </reference>
  <reference>
    <citation>Inder TE, Wells SJ, Mogridge NB, Spencer C, Volpe JJ. Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study. J Pediatr. 2003 Aug;143(2):171-9.</citation>
    <PMID>12970628</PMID>
  </reference>
  <reference>
    <citation>Hüppi PS, Murphy B, Maier SE, Zientara GP, Inder TE, Barnes PD, Kikinis R, Jolesz FA, Volpe JJ. Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics. 2001 Mar;107(3):455-60.</citation>
    <PMID>11230582</PMID>
  </reference>
  <reference>
    <citation>Hüppi PS, Maier SE, Peled S, Zientara GP, Barnes PD, Jolesz FA, Volpe JJ. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res. 1998 Oct;44(4):584-90.</citation>
    <PMID>9773850</PMID>
  </reference>
  <reference>
    <citation>Hoon AH Jr, Lawrie WT Jr, Melhem ER, Reinhardt EM, Van Zijl PC, Solaiyappan M, Jiang H, Johnston MV, Mori S. Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology. 2002 Sep 10;59(5):752-6.</citation>
    <PMID>12221171</PMID>
  </reference>
  <reference>
    <citation>Miller SP, Vigneron DB, Henry RG, Bohland MA, Ceppi-Cozzio C, Hoffman C, Newton N, Partridge JC, Ferriero DM, Barkovich AJ. Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J Magn Reson Imaging. 2002 Dec;16(6):621-32.</citation>
    <PMID>12451575</PMID>
  </reference>
  <reference>
    <citation>Inder TE, Volpe JJ. Mechanisms of perinatal brain injury. Semin Neonatol. 2000 Feb;5(1):3-16. Review.</citation>
    <PMID>10802746</PMID>
  </reference>
  <reference>
    <citation>Melhem ER, Hoon AH Jr, Ferrucci JT Jr, Quinn CB, Reinhardt EM, Demetrides SW, Freeman BM, Johnston MV. Periventricular leukomalacia: relationship between lateral ventricular volume on brain MR images and severity of cognitive and motor impairment. Radiology. 2000 Jan;214(1):199-204.</citation>
    <PMID>10644124</PMID>
  </reference>
  <reference>
    <citation>Ment LR, Bada HS, Barnes P, Grant PE, Hirtz D, Papile LA, Pinto-Martin J, Rivkin M, Slovis TL. Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002 Jun 25;58(12):1726-38. Review.</citation>
    <PMID>12084869</PMID>
  </reference>
  <reference>
    <citation>Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. The Franco-Belgium Collaborative NO Trial Group. Lancet. 1999 Sep 25;354(9184):1066-71. Erratum in: Lancet 1999 Nov 20;354(9192):1826.</citation>
    <PMID>10509497</PMID>
  </reference>
  <reference>
    <citation>Bennett AJ, Shaw NJ, Gregg JE, Subhedar NV. Neurodevelopmental outcome in high-risk preterm infants treated with inhaled nitric oxide. Acta Paediatr. 2001 May;90(5):573-6.</citation>
    <PMID>11430720</PMID>
  </reference>
  <reference>
    <citation>Cheung PY, Peliowski A, Robertson CM. The outcome of very low birth weight neonates (&lt;/=1500 g) rescued by inhaled nitric oxide: neurodevelopment in early childhood. J Pediatr. 1998 Dec;133(6):735-9.</citation>
    <PMID>9842035</PMID>
  </reference>
  <reference>
    <citation>Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, Walsh-Sukys MC, McCaffrey MJ, Cornfield DN, Bhutani VK, Cutter GR, Baier M, Abman SH. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet. 1999 Sep 25;354(9184):1061-5.</citation>
    <PMID>10509496</PMID>
  </reference>
  <reference>
    <citation>Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielli FM, Abman SH, Kinsella JP. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr. 1997 Jul;131(1 Pt 1):70-5.</citation>
    <PMID>9255194</PMID>
  </reference>
  <reference>
    <citation>Subhedar NV, Ryan SW, Shaw NJ. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child Fetal Neonatal Ed. 1997 Nov;77(3):F185-90.</citation>
    <PMID>9462187</PMID>
  </reference>
  <reference>
    <citation>Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med. 2003 Nov 27;349(22):2099-107.</citation>
    <PMID>14645637</PMID>
  </reference>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>September 6, 2006</last_update_submitted>
  <last_update_submitted_qc>September 6, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2006</last_update_posted>
  <keyword>etiology</keyword>
  <keyword>pathology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

